Metaverse Clinic for Pregnant Women With Subclinical Hypothyroidism: Prospective Randomized Study
Open Access
- 5 February 2025
- journal article
- research article
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 27 (1) , e64634
Abstract
Background: Health care is experiencing new opportunities in the emerging digital landscape. The metaverse, a shared virtual space, integrates technologies such as augmented reality, virtual reality, blockchain, and artificial intelligence. It allows users to interact with immersive digital worlds, connect with others, and explore unknowns. While the metaverse is gaining traction across various medical disciplines, its application in thyroid diseases remains unexplored. Subclinical hypothyroidism (SCH) is the most common thyroid disorder during pregnancy and is frequently associated with adverse pregnancy outcomes. Objective: This study aims to evaluate the safety and effectiveness of a metaverse platform in managing SCH during pregnancy. Methods: A randomized controlled trial was conducted at Fujian Provincial Hospital, China, from July 2022 to December 2023. A total of 60 pregnant women diagnosed with SCH were randomly assigned into two groups: the standard group (n=30) and the metaverse group (n=30). Both groups received levothyroxine sodium tablets. Additionally, participants in the metaverse group had access to the metaverse virtual medical consultations and metaverse-based medical games. The primary outcomes were adverse maternal and offspring outcomes, and the secondary outcomes included the neurobehavioral development of offspring and maternal psychological assessments. Results: Of the 30 participants in each group, adverse maternal outcomes were observed in 43% (n=13) of the standard group and 37% (n=11) of the metaverse group (P=.60). The incidence of adverse offspring outcomes was 33% (n=10) in the standard group, compared to 7% (n=2) in the metaverse group (P=.01). The Gesell Development Scale did not show significant differences between the two groups. Notably, the metaverse group demonstrated significantly improved scores on the Self-Rating Depression Scale and the Self-Rating Anxiety Scale scores compared to the standard group (P<.001 and P=.001, respectively). Conclusions: The use of metaverse technology significantly reduced the incidence of adverse offspring outcomes and positively impacted maternal mental health. Maternal adverse outcomes and offspring neurobehavioral development were comparable between the two groups. Trial Registration: Chinese Clinical Trial Registry ChiCTR2300076803; https://www.chictr.org.cn/showproj.html?proj=205905Keywords
This publication has 39 references indexed in Scilit:
- Metaverse in Mental Health: The Beginning of a Long HistoryCurrent Psychiatry Reports, 2024
- The next generation of healthcare ecosystem in the metaverseBiomedical Journal, 2023
- The dark side of the metaverse: The role of gamification in event virtualizationInternational Journal of Information Management, 2023
- Metaverse Surgical Planning with Three-dimensional Virtual Models for Minimally Invasive Partial NephrectomyEuropean Urology, 2023
- Provision of surgical pre-operative patient counseling services through the Metaverse technologyInternational Journal of Surgery, 2022
- Virtual reality balance training to improve balance and mobility in Parkinson’s disease: a systematic review and meta-analysisJournal of Neurology, 2021
- Maternal Mid-Gestation Cytokine Dysregulation in Mothers of Children with Autism Spectrum DisorderJournal of Autism and Developmental Disorders, 2021
- Subclinical hypothyroidism and thyroid autoimmunity in recurrent pregnancy loss: a systematic review and meta-analysisFertility and Sterility, 2020
- Prevalence of depression and anxiety in women with recurrent pregnancy loss and the associated risk factorsArchives of Gynecology and Obstetrics, 2019
- Association of Thyroid Function Test Abnormalities and Thyroid Autoimmunity With Preterm BirthJAMA, 2019